FdaApplication

ANDA 205935

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSANDOZ INC
application_typeANDA
approval_date2019-05-14

Products (1)

ProductActive ingredientStrengthDosage form
FULVESTRANTFULVESTRANT250MG/5ML (50MG/ML)SOLUTION;INTRAMUSCULAR

1 product